“Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients With Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials ”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s375. Accessed January 20, 2026. https://skin.dermsquared.com/skin/article/view/2675.